Patent details

EP2451814 Title: FUSED IMIDAZOLES AND COMPOSITIONS COMPRISING THEM FOR THE TREATMENT OF PARASITIC DISEASES, SUCH AS E.G. MALARIA.

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP2451814
WO Application Number:
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP10733107.6
WO Publication Number:
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Bermuda (BM)
Publications:

Dates

Filing date:
09/07/2010
Grant date:
09/04/2014
EP Publication Date:
09/04/2014
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
09/04/2014
EP B1 Publication Date:
09/04/2014
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
01/07/2014
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
08/07/2030
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
24/12/2015
 
 

 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056, BASEL, Switzerland (CH)

Historical Applicant/holder

From:
24/12/2015
To:
24/12/2015

 

Name:
Novartis International Pharmaceutical Ltd.
Address:
131 Front Street, HM 12, Hamilton, Bermuda (BM)

From:
09/04/2014
To:
24/12/2015

 

Name:
IRM LLC
Address:
131 Front Street, HAMILTON, HM LX, Bermuda (BM)

Domicile Holder

Name:
ir. M.F.J.M. Ketelaars c.s.
From:
09/04/2014
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Inventor

1

Name:
CHATTERJEE, Arnab K.
Address:
SAN DIEGO CALIFORNIA 92103, United States of America (US)

2

Name:
NAGLE, Advait
Address:
SAN DIEGO CALIFORNIA 92128, United States of America (US)

3

Name:
WU, Tao
Address:
SAN DIEGO CALIFORNIA 92122, United States of America (US)

4

Name:
TULLY, David
Address:
SAN DIEGO CALIFORNIA 92130, United States of America (US)

5

Name:
KUHEN, Kelli L.
Address:
SOLANA BEACH CALIFORNIA 92075, United States of America (US)

Priority

Priority Patent Number:
224433 P
Priority Date:
09/07/2009
Priority Country:
United States of America (US)

Classification

Main IPC Class:
C07D 487/04;
IPC or IDT classification:
A61K 31/4985; A61P 33/02; A61P 33/06; C07D 487/14; C07D 519/00;

Publication

Bulletin

1

Bulletin Heading:
CO
Journal edition number:
17/16
Publication date:
28/04/2016
Description:
Changes in the Netherlands Patent Register

2

Bulletin Heading:
CO
Journal edition number:
17/16
Publication date:
28/04/2016
Description:
Changes in the Netherlands Patent Register

3

Bulletin Heading:
EP3
Journal edition number:
2014/28
Publication date:
09/07/2014
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

4

Bulletin Heading:
EP2
Journal edition number:
2014/16
Publication date:
16/04/2014
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
201415
Publication date:
09/04/2014
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Merge
Deed Number:
RC201600729C
Date Registered:
24/12/2015
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
Dennemeyer & Associates
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Novartis International Pharmaceutical Ltd.
Address:
131 Front Street, HM 12, Hamilton, Bermuda (BM)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC201600729D
Date Registered:
24/12/2015
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
Dennemeyer & Associates
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056, BASEL, Switzerland (CH)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
31/07/2026
Annual Fee Number:
17
Annual Fee Amount:
1100 Euro
Last Annual Payment Date:
27/06/2025
Last Annual Fee Paid Number:
16
Last Annual Fee Paid Amount:
1000 Euro
Payer:
Computer Patent Annuities Limited (CPA)
Filing date Document type Document Description Number of pages File Type
24/12/2015 RFC Correspondence Accompanying letter deed 3 PDF /7/0/1/3/3/0510733107/docs/ep10733107.6_0_rfc20160420022719226.pdf
24/12/2015 RFC Correspondence Accompanying letter deed 2 PDF /7/0/1/3/3/0510733107/docs/ep10733107.6_2_rfc20160420022654138.pdf
24/12/2015 RFC Correspondence Accompanying letter deed 2 PDF /7/0/1/3/3/0510733107/docs/ep10733107.6_6_rfc20160421125458132.pdf
02/07/2014 Outgoing Correspondence Outgoing Letter 1 PDF /7/0/1/3/3/0510733107/docs/ep10733107.6_3_outgoingcorrespondence20140702.pdf
01/07/2014 Claims Translated claims 5 PDF /7/0/1/3/3/0510733107/docs/ep10733107.6_4_claims20140701.pdf
01/07/2014 Incoming Correspondence Paper Accompanying letter incoming document 2 PDF /7/0/1/3/3/0510733107/docs/ep10733107.6_5_incomingcorrespondencepaper20140701.pdf
01/07/2014 Outgoing Correspondence Outgoing Letter 1 PDF /7/0/1/3/3/0510733107/docs/ep10733107.6_7_outgoingcorrespondence20140701.pdf
12/06/2014 Incoming Correspondence Paper Correspondence address details 1 PDF /7/0/1/3/3/0510733107/docs/ep10733107.6_1_incomingcorrespondencepaper20140612.pdf